Atea/$AVIR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Atea
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Ticker
$AVIR
Sector
Primary listing
Employees
55
Headquarters
Website
Atea Metrics
BasicAdvanced
$433m
-
-$1.94
0.26
-
Price and volume
Market cap
$433m
Beta
0.26
52-week high
$6.45
52-week low
$2.46
Average daily volume
372k
Financial strength
Current ratio
7.817
Quick ratio
7.587
Total debt to equity
0.306
Profitability
EBITDA (TTM)
-178.981
Effective tax rate (TTM)
3.75%
Management effectiveness
Return on assets (TTM)
-28.75%
Return on equity (TTM)
-44.34%
Valuation
Price to book
1.54
Price to tangible book (TTM)
1.54
Price to free cash flow (TTM)
-3.352
Free cash flow yield (TTM)
-29.84%
Free cash flow per share (TTM)
-1.62
Growth
Earnings per share change (TTM)
-2.76%
3-year earnings per share growth (CAGR)
11.75%
What the Analysts think about Atea
Analyst ratings (Buy, Hold, Sell) for Atea stock.
Atea Financial Performance
Revenues and expenses
Atea Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Atea stock?
Atea (AVIR) has a market cap of $433M as of April 30, 2026.
What is the P/E ratio for Atea stock?
The price to earnings (P/E) ratio for Atea (AVIR) stock is 0 as of April 30, 2026.
Does Atea stock pay dividends?
No, Atea (AVIR) stock does not pay dividends to its shareholders as of April 30, 2026.
When is the next Atea dividend payment date?
Atea (AVIR) stock does not pay dividends to its shareholders.
What is the beta indicator for Atea?
Atea (AVIR) has a beta rating of 0.26. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.